Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

INVA 10.32 -0.90 (-8.02%)
price chart
Innoviva Inc (NASDAQ:INVA) Given Consensus Rating of "Hold" by Analysts
Innoviva logo Innoviva Inc (NASDAQ:INVA) has been given an average rating of “Hold” by the six research firms that are covering the firm.
Innoviva: On Track To Buy Back The Whole Company
I have already reviewed the performance of GSK's (NYSE:GSK) new respiratory drugs in another article, so this one will focus on the issues specific to its development partner Innoviva (NASDAQ:INVA) (formerly called Theravance). Innoviva ended 2015 with ...
Innoviva: What Happens When Generic Advair Hits The Market?
A few days ago, Innoviva (NASDAQ:INVA) changed name (before the company had called itself Theravance (THRX)) and immediately sold off, as Mylan (NASDAQ:MYL) finally presented an ANDA for a generic Advair.
Stock Tracing Lower on the Week Innoviva, Inc. (:INVA)
Innoviva, Inc. (:INVA) stock has moved in a downward direction over the past week, yielding losses for investors. Based on the recent close, the shares have dropped -6.35% over the past five trading days.
Could Innoviva Inc Rise Even More? The Stock Had Another Big Increase Today
The stock of Innoviva Inc (NASDAQ:INVA) is a huge mover today! The stock is up 1.05% or $0.11 after the news, hitting $11.02 per share.
Form 8-K Innoviva, Inc. For: May 24
On May 24, 2016, GlaxoSmithKline plc (“GSK”) and Innoviva, Inc. distributed a press release announcing headline data from the Salford Lung Study (“SLS”) of RELVAR� ELLIPTA� 100/25mcg (fluticasone furoate/vilanterol or “FF/VI”) in Chronic Obstructive ...
Innoviva, GlaxoSmithKline Drug Shows Statistically Significant Reduction In ...  Sonoran Weekly Review
Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta  Yahoo News
Form 8-K Innoviva, Inc. For: Jun 10
On June 10, 2016, Innoviva, Inc. (the “Company”) executed an Office Lease Agreement (the “Office Lease”) with 2000 Sierra Point Parkway LLC (“Sierra Point”) for approximately 8,427 square feet of office space (with approximately 6,700 of net usable ...
Theravance (THRX) Changes Name, Ticker to Innoviva (INVA)
Theravance, Inc. (NASDAQ: THRX) announced that it changed its name to Innoviva, Inc., effective January 7, 2016. In addition to Innoviva's new name, the company has also unveiled a new corporate identity and website, available at www.
Glaxo/Innoviva Expedite Closed Triple Combination NDA Filing
GlaxoSmithKline plc GSK with partner, Innoviva, Inc. INVA, announced that it has accelerated the timeline for filing a New Drug Application (NDA) for the once-daily closed triple combination therapy (FF/UMEC/VI) for the treatment of patients with ...
Glaxo/Innoviva's Closed Triple Combination Tops Phase III
GlaxoSmithKline plc (GSK - Analyst Report) , with its partner Innoviva, Inc. (INVA - Snapshot Report) , announced positive top-line data from the phase III FULFIL study on the closed triple combination therapy (fluticasone furoate, FF/umeclidinium, ...
GSK, Innoviva announce positive results from phase III FULFIL study of ...
Glaxo/Innoviva triple combo COPD treatment passes phase III  Proactive Investors UK